REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
13/04/2026
Voltar para busca
Dado oficial do USPTO
CUREVAC
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
14/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 42, 44
Data de depósito
03/09/2019
Data de registro
13/04/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/04/2021
Última transação
14/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
3
Tipo de titular
94
Localização do titular
TÜBINGEN, DE
Examinador
MARTIN, LIEF ANDREW
Unidade examinadora
M30
Localização atual
TMO LAW OFFICE 112
Descrição da marca
The mark consists of the stylized term "CUREVAC" with the term "CURE" appearing in orange, the term "VAC" appearing in blue, and with a blue curved line beginning at the letter "V", and extending to the right and below the wording.
Titulares e representantes
Titulares
C. S. (pessoa física)
CureVac AG
Representantes
Jennifer Fraser DYKEMA GOSSETT PLLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical reagents and biomoleculesin particular biological macromoleculesfor industrial or scientific purposes; Reagents for research purposes
Classe 5
Chemical preparations for medical usefor therapeutic and prophylactic treatment of neurologicalneuromuscularneurodegenerativeinfectious and cardiovascular diseasesof autoimmune diseases and cancer diseasesof tumoursof allergiesof metabolic diseasesof heritable genetic diseasesfor therapies replacing proteins or enzymes; pharmaceutical preparationsimmunostimulantsin particular for human or veterinary medical purposes; pharmaceutical preparationsvaccinesin particular for human or veterinary medical purposes; pharmaceutical preparationsadjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromoleculesin particular for human or veterinary purposes for the treatment of neurologicalneuromuscularneurodegenerative and cardiovascular diseasesfor the treatment of infectious diseasesautoimmune diseases and tumoursfor treatment of cancersfor treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy productsnucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical usein particular substances for food supplementsdietary food supplements; Peptide carrier molecules for association with a biological macromoleculefor medical usefor use in facilitating delivery of a wide range of medicinal substances; Peptidic carrier molecule for preparing a pharmaceutical compositionfor medical use as a protein delivery preparation to expedite or improve delivery of a therapeutic macromolecule or prophylactic biological marcomolecule; Peptide carrier moleculesold in combination with a biological macromolecule for preparing a pharmaceutical compositionfor medical use as a protein delivery preparation to expedite or improve delivery of a therapeutic drug or prophylactic drug
Classe 42
Scientific and technological services and researchin particular scientific research for identificationtesting and characterisation of biological macromolecules; medical testing servicespre-clinical and clinical testing of macromolecules; scientific research in the nature of discovery of biological macromolecules; Laboratory servicesrelated to custom manufacturing of pharmaceutical ingredientsfor identificationtesting and characterisation of biological macromolecules
Classe 44
Medical and veterinary servicesin particular for therapeutic and prophylactic treatment of cancer diseasesinfectious diseasesautoimmune diseases or allergies; Medical and veterinary services for treating of hereditary disorders; Medical and veterinary services for protein or enzyme supplement therapy for therapeutic or prophylactic treatment of neurologicalneuromuscularneurodegenerative and cardiovascular diseases and for treatment of endocrinological or metabolic disorders
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/03/2023
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
30/09/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30/09/2021
ES7R
TEAS SECTION 7 REQUEST RECEIVED
30/04/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
13/04/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/01/2021
PUBO
PUBLISHED FOR OPPOSITION
26/01/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/01/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/12/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
17/12/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
17/12/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
17/12/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
17/12/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/12/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/12/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/12/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
30/06/2020
GNRT
NON-FINAL ACTION E-MAILED
30/06/2020
CNRT
NON-FINAL ACTION WRITTEN
30/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/06/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/06/2020
ALIE
ASSIGNED TO LIE
15/06/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/06/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/12/2019
GNRT
NON-FINAL ACTION E-MAILED
09/12/2019
CNRT
NON-FINAL ACTION WRITTEN
09/12/2019
DOCK
ASSIGNED TO EXAMINER
05/12/2019
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
14/09/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/09/2019
NWAP
NEW APPLICATION ENTERED
06/09/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CUREVAC ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.